Cargando…

Maternal Serum Macrophage Inhibitory Cytokine-1 as a Biomarker for Ectopic Pregnancy in Women with a Pregnancy of Unknown Location

BACKGROUND: Ectopic pregnancy (EP) occurs in 1–2% of pregnancies, but is over-represented as a leading cause of maternal death in early pregnancy. It remains a challenge to diagnose early and accurately. Women often present in early pregnancy with a ‘pregnancy of unknown location’ (PUL) and the diag...

Descripción completa

Detalles Bibliográficos
Autores principales: Skubisz, Monika M., Brown, Jeremy K., Tong, Stephen, Kaitu’u-Lino, Tu’uhevaha, Horne, Andrew W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688885/
https://www.ncbi.nlm.nih.gov/pubmed/23824055
http://dx.doi.org/10.1371/journal.pone.0066339
_version_ 1782274187711217664
author Skubisz, Monika M.
Brown, Jeremy K.
Tong, Stephen
Kaitu’u-Lino, Tu’uhevaha
Horne, Andrew W.
author_facet Skubisz, Monika M.
Brown, Jeremy K.
Tong, Stephen
Kaitu’u-Lino, Tu’uhevaha
Horne, Andrew W.
author_sort Skubisz, Monika M.
collection PubMed
description BACKGROUND: Ectopic pregnancy (EP) occurs in 1–2% of pregnancies, but is over-represented as a leading cause of maternal death in early pregnancy. It remains a challenge to diagnose early and accurately. Women often present in early pregnancy with a ‘pregnancy of unknown location’ (PUL) and the diagnosis and exclusion of EP is difficult due to a lack of reliable biomarkers. A serum biomarker able to clearly distinguish between EP and other pregnancy outcomes would greatly assist clinicians in diagnosing and safely managing PULs. This study evaluates the ability of maternal serum macrophage inhibitory cytokine-1 (MIC-1) levels to differentiate between EP and other pregnancy outcomes in women with a PUL. METHODS: Sera were collected from 120 women with a PUL at first clinical presentation and assayed for MIC-1 by ELISA. Results were classified according to ultimate pregnancy outcome and the discriminatory ability of MIC-1 to diagnose EP was assessed. RESULTS: Serum MIC-1 levels were lower in women with histologically confirmed (definite) EP (dEP) (median 552 ng/mL; interquartile range (IQR) 414–693 ng/mL) compared to women with definite viable intra-uterine pregnancies (dVIUPs) (722 ng/mL; IQR 412–1122 ng/mL), and higher when compared to women with definite non-viable intra-uterine pregnancies (dNVIUPs) (465 ng/mL; IQR 341–675 ng/mL). MIC-1 levels were significantly higher in women with dEP compared to women whose PULs resolved without medical intervention (srPUL) (401 ng/mL; IQR 315–475 ng/mL) (p<0.003). There were no women with an ectopic pregnancy where serum MIC-1>1000 ng/mL. CONCLUSION: Serum MIC-1 levels in PUL were not able to categorically diagnose EP, however, MIC-1 could distinguish women with an EP that required medical intervention and those women whose PULs spontaneously resolved. A single serum MIC-1 measurement also excluded EP at levels above 1000 ng/mL. MIC-1 may play a role in the development of a combined assay of biomarkers for the diagnosis of EP.
format Online
Article
Text
id pubmed-3688885
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-36888852013-07-02 Maternal Serum Macrophage Inhibitory Cytokine-1 as a Biomarker for Ectopic Pregnancy in Women with a Pregnancy of Unknown Location Skubisz, Monika M. Brown, Jeremy K. Tong, Stephen Kaitu’u-Lino, Tu’uhevaha Horne, Andrew W. PLoS One Research Article BACKGROUND: Ectopic pregnancy (EP) occurs in 1–2% of pregnancies, but is over-represented as a leading cause of maternal death in early pregnancy. It remains a challenge to diagnose early and accurately. Women often present in early pregnancy with a ‘pregnancy of unknown location’ (PUL) and the diagnosis and exclusion of EP is difficult due to a lack of reliable biomarkers. A serum biomarker able to clearly distinguish between EP and other pregnancy outcomes would greatly assist clinicians in diagnosing and safely managing PULs. This study evaluates the ability of maternal serum macrophage inhibitory cytokine-1 (MIC-1) levels to differentiate between EP and other pregnancy outcomes in women with a PUL. METHODS: Sera were collected from 120 women with a PUL at first clinical presentation and assayed for MIC-1 by ELISA. Results were classified according to ultimate pregnancy outcome and the discriminatory ability of MIC-1 to diagnose EP was assessed. RESULTS: Serum MIC-1 levels were lower in women with histologically confirmed (definite) EP (dEP) (median 552 ng/mL; interquartile range (IQR) 414–693 ng/mL) compared to women with definite viable intra-uterine pregnancies (dVIUPs) (722 ng/mL; IQR 412–1122 ng/mL), and higher when compared to women with definite non-viable intra-uterine pregnancies (dNVIUPs) (465 ng/mL; IQR 341–675 ng/mL). MIC-1 levels were significantly higher in women with dEP compared to women whose PULs resolved without medical intervention (srPUL) (401 ng/mL; IQR 315–475 ng/mL) (p<0.003). There were no women with an ectopic pregnancy where serum MIC-1>1000 ng/mL. CONCLUSION: Serum MIC-1 levels in PUL were not able to categorically diagnose EP, however, MIC-1 could distinguish women with an EP that required medical intervention and those women whose PULs spontaneously resolved. A single serum MIC-1 measurement also excluded EP at levels above 1000 ng/mL. MIC-1 may play a role in the development of a combined assay of biomarkers for the diagnosis of EP. Public Library of Science 2013-06-18 /pmc/articles/PMC3688885/ /pubmed/23824055 http://dx.doi.org/10.1371/journal.pone.0066339 Text en © 2013 Skubisz et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Skubisz, Monika M.
Brown, Jeremy K.
Tong, Stephen
Kaitu’u-Lino, Tu’uhevaha
Horne, Andrew W.
Maternal Serum Macrophage Inhibitory Cytokine-1 as a Biomarker for Ectopic Pregnancy in Women with a Pregnancy of Unknown Location
title Maternal Serum Macrophage Inhibitory Cytokine-1 as a Biomarker for Ectopic Pregnancy in Women with a Pregnancy of Unknown Location
title_full Maternal Serum Macrophage Inhibitory Cytokine-1 as a Biomarker for Ectopic Pregnancy in Women with a Pregnancy of Unknown Location
title_fullStr Maternal Serum Macrophage Inhibitory Cytokine-1 as a Biomarker for Ectopic Pregnancy in Women with a Pregnancy of Unknown Location
title_full_unstemmed Maternal Serum Macrophage Inhibitory Cytokine-1 as a Biomarker for Ectopic Pregnancy in Women with a Pregnancy of Unknown Location
title_short Maternal Serum Macrophage Inhibitory Cytokine-1 as a Biomarker for Ectopic Pregnancy in Women with a Pregnancy of Unknown Location
title_sort maternal serum macrophage inhibitory cytokine-1 as a biomarker for ectopic pregnancy in women with a pregnancy of unknown location
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688885/
https://www.ncbi.nlm.nih.gov/pubmed/23824055
http://dx.doi.org/10.1371/journal.pone.0066339
work_keys_str_mv AT skubiszmonikam maternalserummacrophageinhibitorycytokine1asabiomarkerforectopicpregnancyinwomenwithapregnancyofunknownlocation
AT brownjeremyk maternalserummacrophageinhibitorycytokine1asabiomarkerforectopicpregnancyinwomenwithapregnancyofunknownlocation
AT tongstephen maternalserummacrophageinhibitorycytokine1asabiomarkerforectopicpregnancyinwomenwithapregnancyofunknownlocation
AT kaituulinotuuhevaha maternalserummacrophageinhibitorycytokine1asabiomarkerforectopicpregnancyinwomenwithapregnancyofunknownlocation
AT horneandreww maternalserummacrophageinhibitorycytokine1asabiomarkerforectopicpregnancyinwomenwithapregnancyofunknownlocation